These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 17688663

  • 21. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F, Rezori B, Neef M, Lammert F, Sauerbruch T, Spengler U, Reichel C.
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Liver dysfunction by model for end-stage liver disease score improves mortality prediction in injured patients with cirrhosis.
    Corneille MG, Nicholson S, Richa J, Son C, Michalek J, Wolf SE, Stewart R.
    J Trauma; 2011 Jul; 71(1):6-11. PubMed ID: 21818010
    [Abstract] [Full Text] [Related]

  • 27. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F, Lukowski A.
    J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
    [Abstract] [Full Text] [Related]

  • 28. [Application of Model for end-stage liver disease to predict the prognosis of and curative effect for chronic severe hepatitis].
    Liu Q, Liu Z, Wang TL, Zhang LL.
    Zhonghua Yi Xue Za Zhi; 2005 Jul 06; 85(25):1773-7. PubMed ID: 16253168
    [Abstract] [Full Text] [Related]

  • 29. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M, Roth F, Fimmers R, Brensing KA, Sudhop T, Schild HH, Sauerbruch T.
    Am J Gastroenterol; 2003 May 06; 98(5):1167-74. PubMed ID: 12809844
    [Abstract] [Full Text] [Related]

  • 30. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J, He WF, Tang XE.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul 06; 19(7):416-8. PubMed ID: 17631710
    [Abstract] [Full Text] [Related]

  • 31. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF, Ding JG, Xu DZ, Chen YP, Hong L, Ye ZY, Zheng MH, Fu RQ, Wu JG, Du QW, Chen W, Wang XF, Sheng JF.
    J Viral Hepat; 2009 Jul 06; 16(7):464-70. PubMed ID: 19413694
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.
    J Clin Gastroenterol; 2009 Sep 06; 43(8):773-81. PubMed ID: 19262404
    [Abstract] [Full Text] [Related]

  • 34. Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores.
    Kalabay L, Gráf L, Vörös K, Jakab L, Benko Z, Telegdy L, Fekete B, Prohászka Z, Füst G.
    BMC Gastroenterol; 2007 Mar 29; 7():15. PubMed ID: 17394649
    [Abstract] [Full Text] [Related]

  • 35. Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation.
    Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, Szymanik B, Jarosz K, Wójcicki M, Milkiewicz P.
    Transplant Proc; 2009 Oct 29; 41(8):3114-6. PubMed ID: 19857689
    [Abstract] [Full Text] [Related]

  • 36. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK, Pradhan B, Chaudhary S, Jha SM.
    J Nepal Health Res Counc; 2013 Jan 29; 11(23):9-16. PubMed ID: 23787518
    [Abstract] [Full Text] [Related]

  • 37. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan 29; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 38. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 29; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 39. Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner?
    Biselli M, Gitto S, Gramenzi A, Di Donato R, Brodosi L, Ravaioli M, Grazi GL, Pinna AD, Andreone P, Bernardi M.
    Liver Transpl; 2010 Aug 29; 16(8):964-73. PubMed ID: 20677287
    [Abstract] [Full Text] [Related]

  • 40. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
    Brandão A, Fuchs SC, Gleisner AL, Marroni C, Zanotelli ML, Cantisani G.
    Clin Transplant; 2008 Aug 29; 22(5):651-6. PubMed ID: 18549449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.